Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Subst Abus. 2009 Oct-Dec;30(4):295-305. doi: 10.1080/08897070903250084.

Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Author information

  • 1Addictive Behaviors Research Center, Department of Psychology, University of Washington, Seattle, Washington, USA. swbowen@u.washington.edu

Abstract

The current study is the first randomized-controlled trial evaluating the feasibility and initial efficacy of an 8-week outpatient Mindfulness-Based Relapse Prevention (MBRP) program as compared to treatment as usual (TAU). Participants were 168 adults with substance use disorders who had recently completed intensive inpatient or outpatient treatment. Assessments were administered pre-intervention, post-intervention, and 2 and 4 months post-intervention. Feasibility of MBRP was demonstrated by consistent homework compliance, attendance, and participant satisfaction. Initial efficacy was supported by significantly lower rates of substance use in those who received MBRP as compared to those in TAU over the 4-month post-intervention period. Additionally, MBRP participants demonstrated greater decreases in craving, and increases in acceptance and acting with awareness as compared to TAU. Results from this initial trial support the feasibility and initial efficacy of MBRP as an aftercare approach for individuals who have recently completed an intensive treatment for substance use disorders.

PMID:
19904665
[PubMed - indexed for MEDLINE]
PMCID:
PMC3280682
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Write to the Help Desk